Article Sidebar

Submitted
9 February 2025
Accepted
4 June 2025
Published
30 June 2025
Download
PDF
Statistic
Read Counter : 383 Download : 141

Main Article Content

Abstract

Hypertension with congestive heart failure (CHF) results in high disease-related costs, placing a burden on patients, families, and healthcare facilities. Direct medical costs are known to be the highest proportion. This study aims to identify factors associated with direct medical costs in patients with hypertension and CHF and the difference in payment amounts compared to insurance reimbursements. This research uses a cross-sectional design at Hospital X in Lampung Province. The study population consists of patients diagnosed with hypertension and CHF within the period 2020-2022, with samples selected using total sampling. From 101 samples, the total direct medical cost for all cost components was IDR 908,700,216, with an average direct medical cost of IDR 8,997,032. The highest cost component was cardiac catheterization, with a total IDR of 473,081,000 and an average IDR of 36,390,846. The lowest cost component was additional medical expenses, with a total IDR 16,348,780 and an average IDR 166,824. Bivariate analysis showed a significant relationship between direct medical costs and length of hospital stay, insurance classes, and comorbid conditions. In addition, bivariate analysis showed a significant difference between direct medical costs and insurance reimbursement, with a positive discrepancy of IDR 4.437.619. This study concludes that length of stay, insurance classes, and comorbidities are significantly associated with direct medical costs. There is also a significant difference between direct medical costs and the amount of insurance reimbursement.

Keywords

Cost of Illness Congestive Heart Failure Direct Medical cost Hypertension Insurance reimbursement

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Suri, N., & Kylalona, G. (2025). Analysis of Factors Affecting Medical Cost and Insurance Reimbursement Gaps in Hypertension Heart Failure Patients. Jurnal Jaminan Kesehatan Nasional, 5(1), 49–61. https://doi.org/10.53756/jjkn.v5i1.303
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Adane, E., Atnafu, A., & Aschalew, A. Y. (2020). The cost of illness of hypertension and associated factors at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2018. ClinicoEconomics and Outcomes Research, 12, 133–140. https://doi.org/10.2147/CEOR.S234674
  2. Anida, Hartanto, D., & Eka Dewi, R. (2022). Analisis efektivitas Biaya Terapi Gagal Jantung kongestif Pada Pasien Rawat Inap di RSUD Muara Teweh. Jurnal Komunitas Farmasi Nasional, 2(1). https://jkfn.akfaryarsiptk.ac.id/index.php/jkfn/article/view/41
  3. Baroroh, F., & Maghfiroh, R. (2023). Direct Medical Cost And Length of Stay of Hypertension Patients at Private Hospital In Yogyakarta. Jurnal Farmasi Sains Dan Praktis, 27–33. https://doi.org/10.31603/pharmacy.v9i1.6925
  4. Dao, T. D., Tran, H. T. B., Vu, Q. Van, Nguyen, H. T. T., Nguyen, P. Van, & Vo, T. Q. (2024). The annual economic burden incurred by heart failure patients in Vietnam: a retrospective analysis. Journal of Pharmaceutical Policy and Practice, 17(1). https://doi.org/10.1080/20523211.2024.2381099
  5. Dauphinot, V., Garnier-Crussard, A., Moutet, C., Delphin-Combe, F., Späth, H. M., & Krolak-Salmon, P. (2021). Determinants of Medical Direct Costs of Care among Patients of a Memory Center. Journal of Prevention of Alzheimer’s Disease, 8(3), 351–361. https://doi.org/10.14283/jpad.2021.16
  6. DiPiro, J. T., Yee, G. C., Posey, L. M., Haines, S. T., Nolin, T. D., & Ellingrod, V. (2020). Pharmacotheraphy: A Pathophysiologic Approach (Eleventh edition). http://accesspharmacy.mhmedical.com/content.aspx?bookid=1861&secti.
  7. Fauziyah, R. N. (2019). Sampling dan Besar Sampel Bidang Kesehatan Masyarakat dan Klinis. Politeknik Kesehatan Kemenkes Bandung.
  8. Fazzini, L., Casati, M., Martis, A., Perra, F., Rubiolo, P., Deidda, M., Mercuro, G., & Cadeddu Dessalvi, C. (2024). Gender Effect on Clinical Profiles, Pharmacological Treatments and Prognosis in Patients Hospitalized for Heart Failure. In Journal of Clinical Medicine (Vol. 13, Issue 3). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/jcm13030881
  9. Feng, J., Zhang, Y., & Zhang, J. (2024). Epidemiology and Burden of Heart Failure in Asia. In JACC: Asia (Vol. 4, Issue 4, pp. 249–264). Elsevier Inc. https://doi.org/10.1016/j.jacasi.2024.01.013
  10. Hasbi, F., Kurniawan, A. H., Nida, K., Oktaviani, M., & Kemenkes Jakarta, P. (2022). Analysis of Heart Failure Treatment Costs based on the INA-CBGs (Indonesian Case Base Groups) Tariff Package for Patients with National Health Insurance. Asian Journal of Social Science and Management Technology, 4(5), 2313–7410. www.ajssmt.com
  11. Heidenreich, P. A., Fonarow, G. C., Opsha, Y., Sandhu, A. T., Sweitzer, N. K., Warraich, H. J., Butler, J., Hsich, E., Pressler, S. B., Shah, K., Taylor, K., Sabe, M., & Ng, T. (2022). Economic Issues in Heart Failure in the United States. In Journal of Cardiac Failure (Vol. 28, Issue 3, pp. 453–466). Elsevier B.V. https://doi.org/10.1016/j.cardfail.2021.12.017
  12. Hessel, F. P. (2021). Overview of the socio-economic consequences of heart failure. In Cardiovascular Diagnosis and Therapy (Vol. 11, Issue 1). AME Publishing Company. https://doi.org/10.21037/CDT-20-291
  13. Irnizarifka, & Arifianto, H. (2021). The Comprehensive Registry and Research on Heart Failure (CORE-HF): 2 Years Report from Single-Centre Indonesian Heart Failure Clinic Registry. ACI (Acta Cardiologia Indonesiana, 7(2), 13–22.
  14. Istiqomah, Purwidyaningrum, I., & Sunarni, T. (2022). Analisis Biaya Riil Pengobatan Pasien Hipertensi Rawat Inap Terhadap Tarif INA-CBGS’s di RSNU Jombang. Medical Sains : Jurnal Ilmiah Kefarmasian, 7(4).
  15. Kandou, R. D., Tambuwun, C. F. D., Manado, S. R., Kardiologi, B., Vaskular, K., Kedokteran, F., Sam, U., & Manado, R. (2016). Gambaran pasien gagal jantung dengan penyakit hipertensi yang menjalani rawat inap di RSUP Prof. In Jurnal e-Clinic (eCl) (Vol. 4, Issue 2). https://ejournal.unsrat.ac.id/index.php/eclinic/article/view/14680
  16. Kemkes. (2018). Laporan Riskesdas 2018.
  17. Kumalasari, N. D., Rahem, A., Presley, B., & Setiawan, E. (2019). Direct Medical Cost Analysis Among Coronary Heart Disease and Heart Failure Outpatients at One Hospital. Journal of Management and Pharmacy Practice, 9(2). https://doi.org/10.22146/jmpf.38170
  18. Kurniawansyah, M. R., Febrinasari, R. P., & Hikmayani, N. H. (2023). Cost of Illness Pasien dengan Heart Failure with Reduced Ejection Fraction (HFrEF) di RS UNS Periode Maret 2019 - Maret 2020. Plexus Medical Journal, 2(4), 167–176. https://doi.org/10.20961/plexus.v2i4.846
  19. Lam, C. S. P., Arnott, C., Beale, A. L., Chandramouli, C., Hilfiker-Kleiner, D., Kaye, D. M., Ky, B., Santema, B. T., Sliwa, K., & Voors, A. A. (2019). Sex differences in heart failure. In European Heart Journal (Vol. 40, Issue 47, pp. 3859–3868). Oxford University Press. https://doi.org/10.1093/eurheartj/ehz835
  20. Lering, M. N. A., Andayani, T. M., & Purwidyaningrum, I. (2024). Cost analysis and utility index in congestive heart failure patients in Hospital Dr. Moewardi Surakarta. Riset Informasi Kesehatan, 13(1), 70. https://doi.org/10.30644/rik.v13i1.841
  21. Lesyuk, W., Kriza, C., & Kolominsky-Rabas, P. (2018). Cost-of-illness studies in heart failure: A systematic review 2004-2016. BMC Cardiovascular Disorders, 18(1). https://doi.org/10.1186/s12872-018-0815-3
  22. Lippi, G., & Sanchis-Gomar, F. (2020). Global epidemiology and future trends of heart failure. AME Medical Journal, 5. https://doi.org/10.21037/amj.2020.03.03
  23. Lutfi, B., Mutiudin, A. I., Fazri, Y. N., Keperawatan, F., Bhakti, U., & Tasikmalaya, K. (2023). Hubungan Support System Dengan Self Management Pasien Congestive Heart Failure (CHF) di Poli Jantung. E-Indonesian Journal of Health and Medical, 3. http://ijohm.rcipublisher.org/index.php/ijohm
  24. Manda, Y. R., & Baradhi, K. M. (2023, May 27). Catheterization Risks and Complications. In: StatPearls [Internet]. Treasure Island (FL): StatPearls; BioMed Central Ltd. https://doi.org/10.1186/s42466-020-00059-z
  25. Mandasari, U. S., Pratiwi, L., & Rizkifani, S. (2022). Identifikasi Penggolongan Obat Berdasarkan Peresepan Obat Hipertensi di Instalasi Rawat Jalan Rumah Sakit. Journal Syifa Sciences and Clinical Research, 4(1). https://doi.org/10.37311/jsscr.v4i2.14028
  26. Muharram, F. R., Multazam, C. E. C. Z., Mustofa, A., Socha, W., Andrianto, Martini, S., Aminde, L., & Yi-Li, C. (2024). The 30 Years of Shifting in The Indonesian Cardiovascular Burden—Analysis of The Global Burden of Disease Study. Journal of Epidemiology and Global Health, 14(1), 193–212. https://doi.org/10.1007/s44197-024-00187-8
  27. Munawaroh, S., & Sulistiadi, W. (2019). Perbedaan Tarif INA-CBG’s Dengan Tarif Riil Rumah Sakit Pada Pasien BPJS Kasus Stroke Iskemik Rawat Inap Kelas I Di RS PON Tahun 2018. MARSI, 3(2). http://ejournal.urindo.ac.id/index.php/MARSI
  28. Nilansari, A. F., Yasin, N. M., & Puspandari, D. A. (2021). Analisis Tarif INA-CBGs Pasien Hipertensi Rawat Inap di Rumah Sakit Umum Daerah Panembahan Senopati. Indonesian Journal of Clinical Pharmacy, 10(1), 22. https://doi.org/10.15416/ijcp.2021.10.1.22
  29. Oh, G. C., & Cho, H. J. (2020). Blood pressure and heart failure. In Clinical Hypertension (Vol. 26, Issue 1). BioMed Central Ltd. https://doi.org/10.1186/s40885-019-0132-x
  30. Oktadiana, I., Oetari, & Andayani. (2019). Kesesuaian Biaya Riil Terhadap Tarif INA-CBGS Pada Pasien Hipertensi di Rumah Sakit Umum Daerah Pandan Arang Boyolali Tahun 2017. Jurnal Farmasi Indonesia, 16(2), 106–117. http://ejurnal.setiabudi.ac.id/ojs/index.php/farmasi-indonesia/article/download/439/569/
  31. Pawening, A. S., & Haqi, D. N. (2021). Risk Factors That Associated With Hypertension in Population of Tlatah Village. JPH RECODE , 4(2), 137–143. http://e-journal.unair.ac.id/JPHRECODE
  32. Poznyak, A. V., Sadykhov, N. K., Kartuesov, A. G., Borisov, E. E., Melnichenko, A. A., Grechko, A. V., & Orekhov, A. N. (2022). Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment. In Frontiers in Cardiovascular Medicine (Vol. 9). Frontiers Media S.A. https://doi.org/10.3389/fcvm.2022.959285
  33. Puspitasari, N., & Retno Kusumawati, D. (2017). Evaluasi Tingkat Ketidaktepatan Pemberian Kode Diagnosis dan Faktor Penyebab di Rumah Sakit X Jawa Timur. Jurnal Manajemen Kesehatan, 3(1), 27–38. http://dx.doi.org/10.29241/jmk.v3i1.77
  34. Putri, N., Naser Daulay, A., & Putra Hafiz, A. (2020). Cause Analysis of Budget Deficit in BPJS for Health. Journal of Management and Business Innovations, 02, 2. https://jurnal.uinsu.ac.id/index.php/jombi/article/view/9428
  35. Restyana, A., Admaja, W., & Puspiana, R. (2023). Suitability of Real Cost to Tariff of INA-CBGs of Hypertensive Patients at X General Hospital. Jurnal Mandala Pharmacon Indonesia (JMPI), 10(1), 24–30. https://doi.org/10.35311/jmpi.v10i1.450
  36. Rosiyani, E. A., Witcahyo, E., Herawati, Y. T., Kesehatan, F., & Jember, U. (2021). Perhitungan Cost of Illness (COI) Pasien Hipertensi di Pelayanan Rawat Inap RSD Balung Kabupaten Jember Cost of Illness of Hypertension Inpatients in RSD Balung Kabupaten Jember. Jurnal Ilmu Kesehatan Masyarakat Berkala, 3(2), 117–122. http://journal.univetbantara.ac.id/index.php/jikemb/article/download/1873/pdf/6459
  37. Shahim, B., Kapelios, C. J., Savarese, G., & Lund, L. H. (2023). Global Public Health Burden of Heart Failure: An Updated Review. Cardiac Failure Review, 9. https://doi.org/10.15420/cfr.2023.05
  38. Su, M., Pan, D., Zhao, Y., Chen, C., Xingtian, W., Lu, W., Meng, H., Su, X., & Liang, P. (2022). The direct and indirect effects of length of hospital stay on the costs of inpatients with stroke in Ningxia, China, between 2015 and 2020: A retrospective study using quantile regression and structural equation models. Front Public Health, 10(881273). https://doi.org/10.3389/fpubh.2022.881273
  39. Tandah, M. R., Diana, K., Adisaputra, A. D., Monica, S., & Azzahrah, F. (2023). Direct Medical Costs and Accordance of INA-CBG’sClaims on Covid-19 Patients at Anutapura Hospital. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal), 9(1), 84–98. https://doi.org/10.22487/j24428744.2023.v9.i1.16085
  40. Tran, D. T., Ohinmaa, A., Thanh, N. X., Howlett, J. G., Ezekowitz, J. A., McAlister, F. A., & Kaul, P. (2016). The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis. CMAJ Open, 4(3), E365–E370. https://doi.org/10.9778/cmajo.20150130
  41. WHO. (2023, March 16). Hypertension.
  42. Wierzejska, E., Giernaś, B., Lipiak, A., Karasiewicz, M., Cofta, M., & Staszewski, R. (2020). A global perspective on the costs of hypertension: a systematic review. In Archives of Medical Science (Vol. 16, Issue 5, pp. 1078–1091). Termedia Publishing House Ltd. https://doi.org/10.5114/AOMS.2020.92689
  43. Zawudie, A. B., Lemma, T. D., & Daka, D. W. (2020). Cost of hypertension illness and associated factors among patients attending hospitals in southwest shewa zone, Oromia Regional State, Ethiopia. ClinicoEconomics and Outcomes Research, 12, 201–211. https://doi.org/10.2147/CEOR.S241591